Latest news
Acurx's ~550-Patient Trial Could Support C. diff Treatment, Recurrence Reduction - Stock TitanStock Titan · Mon, 03 Aug 2026 12:00:00 GMTReview outlines effective approaches to reduce recurrent hepatic encephalopathy - News-MedicalNews-Medical · Sat, 01 Aug 2026 02:33:00 GMTReducing the risk of overt hepatic encephalopathy recurrence - EurekAlert!EurekAlert! · Fri, 31 Jul 2026 21:40:47 GMT